2007 Fiscal Year Final Research Report Summary
Development of new anti-cancer drugs constructed with unsaturated alkyl chain
| Project/Area Number |
18590112
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Drug development chemistry
|
|---|
| Research Institution | Kobe Pharmaceutical University |
|---|
Principal Investigator |
SUHARA Yoshitomo Kobe Pharmaceutical University, Department of Hygienic Sciences, Lecturer (30297171)
|
|---|
| Project Period (FY) |
2006 – 2007
|
| Keywords | anti-tumour / unsaturated alkyl chain / genomic drug discovery / synthetic chemistry / isonrenoid / fat-soluble vitamins / vitamin K |
|---|
| Research Abstract |
Our research aim is development of candidates for new anti-cancer drugs based on unsaturated alkyl chain. In this study, we synthesized six kinds of “predictable" vitamin K metabolites. They were introduced vitamin K_2 (menaquinone-2, 3, and 4) molecule to ω-hydroxyl or ω-aldehyde group instead of ω-carboxylic acid becauw the metabolites including ω-carboxylic acid were unstable and unable to use for assay. The requisite analogues were synthesized by coupling the naphthoquinone derivative and side-chain moiety. For the synthesis of side-chain part, we chose geraniol, farnesol and geranylgeraniol as the starting material. While the naphthoquinone part was prepared from 1, 4-diacetoxy-2-methylnaphthoquimne. After coupling reaction, deprotection of protective group gave ω-hydroxyl derivative, and additional oxidative reaction yielded ω-aldehyde derivative. We focused on the apoptosis-inducing activity against HL-60 cells (human leukemia cells). Samples of 5 and 10 μM analogues were succes
… More
sively added to HL-60 cells. The apoptosis activity was determined with a flow cytemetry. The activity of most analogues increased in a dose-dependent manner. Menaquinone (MK)-3 particularly showed the most potent activity around 75% among vitamin K_2 homologues at 10 μM. On the other hand, the potency of MK-4 was approximately 15%, which equaled 20% of MK-3 at the same dose; however, MK-2 and ω-aldehyde analogues did not exhibit such activity. In terms of ω-oxygenated analogues, ω-oxygenated MK-3 decreased the potency compared to MK-3; however it still preserved about 50% potency of MK-3. Interestingly, only ω-oxygenated MK-4 increased the activity more than substrate MK-4 at 10 μM. Thus, the apoptosis-inducing activity of our analogues as well as natural vitamin K homologues exhibited cell selectivity against cancer cells. Our results indicated that metabolites of vitamin K might have potential as biologically active compounds and can provide useful information to develop new drugs based on vitamin K with modification of terminal alkyl group. Less
|
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] 「研究成果報告書概要(欧文)」より2007
Author(s)
Suhara, Yoshitomo ; Murakami, Aya ; Kamao Maya ; Nakagawa Kimie Hirota, Yoshihisa ; Tsugawa Naoko ; Okano Toshio
Organizer
The 26th annual meeting of Medicinal Chemistry Symposium
Place of Presentation
Kanagawa
Year and Date
2007-11-29
-
-
-
-
-
-
